AB&B Bio-Tech Co. Ltd. JS Announces Date for Second Extraordinary General Meeting of 2025

Reuters12-04
AB&B Bio-Tech Co. Ltd. JS Announces Date for Second Extraordinary General Meeting of 2025

AB&B Bio-Tech Co. Ltd. JS has announced that its second extraordinary general meeting of 2025 will be held in Taizhou, Jiangsu, PRC on December 23, 2025. During the meeting, shareholders will consider and vote on the appointment of Mr. LI Jianjun as an independent non-executive director of the company and the re-appointment of Deloitte Touche Tohmatsu as the auditors for the year 2025.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AB&B Bio-Tech Co. Ltd. JS published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251204-11945303), on December 04, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment